We provide an infrastructure that is accelerating research and therapy development, increasing collaboration, improving patient care and helping to support ‘clinical trial readiness’ on an international scale.

TREAT-NMD is internationally recognized for its key role in successfully addressing some of the major issues that face therapeutic development in NMDs. We have a strong track record of advising the scientific and medical community, as well as providing the pharmaceutical industry with essential go-to resources – including education, masterclasses, clinical trial assistance and global data provision – to advance novel treatments for neuromuscular conditions.